News in brief

HFMA responds to omega-3 pregnancy study

There are some good findings in the recent Adelaide omega-3 study on DHA in pregnancy , the Health Food Manufacturers’ Association has pointed out; but it is noteworthy that participants did not DHA throughout the whole 9 months but only in the latter stages of pregnancy.

The research investigated supplementation with 800 mg of dietary docosahexaenoic acid (DHA) per day on more than 2,000 pregnant women, concluding that increased levels do not result in lower levels of postpartum depression in mothers or improved cognitive and language development in their offspring.’s coverage of the study is here.

However the HFMA points out that the positive findings within the study were: A major reduction in the number of children classed as ‘slow developers’; much fewer pre-term and low birth weight babies; improved general health with significant reductions in number of adverse health events, admissions to intensive care and even infant deaths.

“It should be noted that during this latest study the DHA was not consumed throughout the full term of the pregnancy as recommended, but only in the later stages of pregnancy,” HFMA said.

Related News

The NHS backs the balanced diet, but stats show it fails to provide adequate nutrient levels

Supplements – Who needs them? Er, around 85% of working adults, say stats

Fish rich diet may protect young women from heart disease, study suggests

Lord: “One of my key objectives in this new role is to look at how we are able to channel and improve HFMA efforts in vocalising our messages."

New chair promises to make UK supplements group more vocal

Vitamin D and calcium combination could help pregnant women with condition that can lead to type 2 diabetes and newborn complications, say researchers.

Calcium and vitamin D may improve metabolic profile of women with 'pregnancy diabetes'

Pregnant women should take more micronutrients aside from iron and folic acid.© iStock

Micronutrient supplementation for mothers boosts infant cognitive health: Follow-up study